Company profile: Centrillion Technologies
1.1 - Company Overview
Company description
- Provider of genomics and DNA analysis technologies for personalized medicine, life sciences research, and bioinformatics, offering whole genome genotyping assays; spatial transcriptomics at micron-scale resolution; high-throughput virus detection using ATOM chips; SARS-CoV-2 whole genome sequencing on QuadCore chips; VirusHunter assays for SARS-CoV-2 and Influenza A/B; and customizable ATOM chips for detecting pathogens, antibiotic resistance genes, and controls.
Products and services
- ATOM Chips: Customizable chips detect 56 pathogens, 16 antibiotic resistance genes, and 6 controls, enabling tailored multi-pathogen screening with built-in controls
- Spatial Transcriptomics: Micron-scale technology quantitatively detects RNA targets with spatial resolution, enabling precise spatial gene-expression measurements for life sciences research
- Whole Genome Genotyping: Ligation–extension-based assays execute human whole-genome genotyping, delivering genotype data for personalized medicine, life sciences research, and bioinformatics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Centrillion Technologies
Diagenode
HQ: Belgium
Website
- Description: Provider of instruments and reagents for life science research and molecular diagnostics, including ultrasound-based sample preparation and DNA/RNA shearing (Bioruptor), high molecular weight DNA shearing for long-read sequencing (Megaruptor), automation for ChIP and epigenetic assays (IP-Star), epigenomics profiling services, and ChIP and DNA methylation kits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diagenode company profile →
PhoreMost
HQ: United Kingdom
Website
- Description: Provider of phenotypic screening and targeted protein degradation solutions, including the SITESEEKER® platform using PROTEINi® libraries to identify novel drug targets and druggable sites in live cells, and GlueSEEKER™ to discover molecular glue degraders. Offers an oncology-focused pipeline of first-in-class targets and E3 ligase-based degraders, and partnering services applying SITESEEKER® across therapeutic areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PhoreMost company profile →
Covalon
HQ: Canada
Website
- Description: Provider of healthcare technologies for wound care and IV site protection, including CovaWound Foam non-adherent dressings, CovaWound Hydrocolloid Dressings for light exuding wounds, ColActive PLUS Ag collagen dressings with silver for antimicrobial protection, IV Clear transparent dressings to secure IV sites, and VALGuard to safeguard IV connections and reduce infection risk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Covalon company profile →
Avalyn Pharma
HQ: United States
Website
- Description: Provider of inhaled therapies for idiopathic pulmonary fibrosis and other respiratory diseases, advancing direct-lung delivery candidates including AP01 (Phase 2b-ready inhaled pirfenidone), AP02 (reformulated inhaled nintedanib; Phase 1a completed), AP02-DP (dry powder nintedanib with equivalent pulmonary bioavailability), AP03 (fixed-dose inhaled pirfenidone+nintedanib), and AP04 (inhaled imatinib for PAH).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avalyn Pharma company profile →
Puridify
HQ: United Kingdom
Website
- Description: Provider of R&D in bioprocessing technologies and services to advance industrial biomolecule manufacture, including OptiRun Service Solutions for maintenance, upgrades, repairs, and training of Cytiva assets; biomanufacturing process development and optimization; scientific support; training and education; and online tools for equipment, chromatography, and filtration management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Puridify company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Centrillion Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Centrillion Technologies
2.2 - Growth funds investing in similar companies to Centrillion Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Centrillion Technologies
4.2 - Public trading comparable groups for Centrillion Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →